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PERSPECTIVES ON DRUGS 
New developments in Europe’s 
cannabis market
Transnational criminal organisations are involved in the 
production of cannabis for domestic markets, and are also 
exporting the drug to other European countries. This POD 
takes a look at some of the main features of Europe’s cannabis 
market — with a specific focus on herbal material — and at 
some of the important changes taking place.
It is difficult to estimate with any certainty the extent of 
cannabis cultivation and the amount of the drug produced in 
Europe. Most of the available information is the result of law 
enforcement activities, and thus reflects the priorities of law 
enforcement agencies and the resources committed to the 
disruption of cannabis supply. This data can provide, however, 
useful insights into cultivation settings in Europe and the 
different criminal groups involved.
I  Cannabis production in Europe
The 1970s saw the emergence of serious cultivation and 
breeding of cannabis plants, with growers in North America 
and Europe working to develop plants that could grow in a 
wider range of conditions, produce higher yields and higher-
potency products (Decorte, 2010; UNODC, 2006). During the 
1980s, the Netherlands emerged as the centre of cannabis 
production and know-how in Europe. Over time, the export of 
Dutch knowledge, combined with the spread of technological 
developments, has led to a trend in several European 
countries (mostly western) towards ‘import substitution’ 
(Jansen, 2002; Potter, 2008). This has involved domestic 
production of cannabis increasingly supplying domestic 
consumption, and reducing reliance on imported products.
Europe has long been one of the world’s 
largest consumer markets for cannabis 
resin. The European market for cannabis 
is now increasingly dominated by herbal 
products. This change in the market 
shares of the two types of cannabis 
products is the result of a shift in how the 
market is supplied, driven by increased 
access to specialist knowledge and 
technology. Cultivation of cannabis 
is spreading across Europe, and as 
this happens, the distances between 
producers of herbal cannabis and the 
consumers of the drug are shortening.  
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Cannabis is a plant that lends itself to a variety of growing 
conditions, ranging from indoor hydroponic (without soil) 
settings to growth in natural outdoor settings such as fields 
and forests. Indoor cannabis cultivation techniques were 
first developed in the Netherlands during the mid-1980s to 
avoid detection by the authorities and to overcome climate 
limitations. Use of controlled growing conditions and 
genetically selected strains can allow growers to obtain four 
to six harvests a year, which are of a higher yield and produce 
material with higher potency than would have been possible in 
the past (Potter and Duncombe, 2012; Vanhove et al., 2012). 
Indoor cultivation has become very attractive to cannabis 
growers across Europe. It is now reported in 26 European 
countries, and is identified as the dominant mode of cannabis 
production in 16 of them (EMCDDA, 2012a).
Successful outdoor cultivation of cannabis depends upon a 
number of factors, including natural daylight cycles, soil, water 
supply and plant strains. Outdoor-grown crops produce one 
or two harvests a year. Although outdoor growing is reported 
in most European countries, it appears to predominate over 
indoor settings mostly in southern and eastern areas, where 
the climate is more favourable.
I  Scale of cannabis cultivation in Europe  
Herbal cannabis production is now widespread in Europe, 
and plantations have been discovered in all countries. The 
Netherlands and the United Kingdom are currently reporting 
the highest number of detected production sites, with several 
thousand being taken down every year in each of the two 
countries. The next-highest numbers of sites are reported by 
Belgium and Poland, where between 1 000 and 1 500 sites 
were discovered in 2012.
The scale of cannabis cultivation sites commonly varies from 
a few plants to several hundred, with large sites of over 1 000 
plants being reported in seven countries in 2012. An increase 
in the size of cultivation sites has been reported in France 
and Finland, possibly indicating a professionalisation of the 
activity. Four other countries, most of which have detected 
large sites, have observed a reduction in the size of the sites 
discovered (Czech Republic, Greece, United Kingdom and 
Norway). 
Although some growers cultivate the plant solely for personal 
or friends’ use, commercial growers, driven by the prospect 
of financial gain, are now reported across Europe. The use 
of large-scale production facilities by criminal groups is 
increasing in many countries, while some of them tend 
now to run multiple small-scale plantations to mitigate 
risks of detection. The criminal groups involved in cannabis 
production in Europe are numerous, and there is evidence of 
a high degree of organisation and specialisation within the 
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trade. Examples of criminal organisations that have been 
identified as playing an important part in cannabis production 
are groups of Vietnamese origin, which are active in central, 
western and northern Europe, motorcycle gangs in Finland 
and armed groups in Turkey. 
Seizures of whole cannabis plants are generally thought to be 
an indicator of domestic cultivation — that is, the plants are 
assumed to have been grown in the country where they were 
seized. A number of facts support this assumption: whole 
cannabis plants are bulky and difficult to hide; the plants are 
usually dried and non-consumable parts are removed before 
being trafficked for retail distribution and sale. With over 30 
000 cases in 2012, the number of seizures of cannabis plants 
in Europe has doubled in five years. Millions of cannabis 
plants are confiscated every year in Europe; with just under 
7 million seized in 2012, this was nearly triple the quantity 
reported five years earlier. Some countries only report 
seizures of plants in weight; in 2012, interceptions in these 
countries totalled 45 tonnes, a 50 % increase compared to 
2007.
Cultivation is reported to be increasing in several countries 
including Ireland, Slovenia, Slovakia and the United Kingdom. 
Greece and Poland report increasing indoor cultivation. The 
number of cannabis plantations dismantled is increasing 
in Belgium, the Czech Republic, Croatia, Poland and 
Romania. This could be indicative of an increase in domestic 
production. However, the sizes and settings of plantations 
vary considerably, and as law enforcement agencies become 
more aware of the phenomenon, they are getting better at 
detecting such sites.
Developments in cannabis supply have been accompanied by 
a shift from resin to herbal cannabis consumption in Europe. 
Consumption of herbal cannabis has been increasing in the 
last 10 years and has now overtaken that of resin in Europe 
overall (EMCDDA, 2012a). Of the estimated 2 050 tonnes 
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of cannabis consumed every year in the European Union 
and Norway, about 60 % (1 280 tonnes) is herbal cannabis 
and the remainder is resin. While consumption of resin is 
concentrated in a few countries, the use of herbal cannabis 
is more evenly spread across Europe. The United Kingdom is 
estimated to be the largest market, accounting for 24 % of all 
herbal cannabis consumed in Europe, followed by Germany 
(16 %), Spain (15 %) and France (11 %). 
There has always been a large variation in the content of 
THC — the main psychoactive ingredient — in cannabis 
across Europe, with highly potent material being reported on 
occasion. There are current concerns about the public health 
implications of increased consumption of highly potent 
herbal products that are low in CBD — a cannabinoid with 
antipsychotic properties (see video).
I Production and trafficking areas in Europe
Cannabis production in Europe is a major challenge for drug 
law enforcement: it is difficult to detect, especially when 
occurring indoors, and trafficking — often within countries or 
within the Schengen open borders area, and requiring little 
crossing of the external borders of the European Union — is 
more difficult to interdict compared with imports of resin. This 
is reflected in the tentative interdiction rates of around 40 % 
for resin and less than 10 % for herb in the European Union.
In most countries, the produce of cannabis plantations is 
destined for local drug markets. In a few countries, however, 
cannabis is also produced for export. Some geographical 
patterns can be observed in herbal cannabis supply in Europe 
by looking at seizures and their relative proportion of the 
market.
South/South-East Europe
The Western Balkans countries are a source of herbal 
cannabis consumed in the European Union, with cultivation 
occurring in Albania, in particular, but also in Bosnia-
Herzegovina, Kosovo (1), Montenegro, Serbia and the former 
Yugoslav Republic of Macedonia. Herbal cannabis originating 
in these countries is trafficked into the European Union 
through Greece, Croatia or Italy. This product, however, grown 
outdoors, is of comparatively poor quality. After exportation, 
it is sometimes mixed with domestic products, and then sold 
for a higher price. This practice is reported in Greece. Evidence 
points to Greece being a growing trafficking hub for herbal 
cannabis. In 2012, Greece reported an annual increase of 
two-thirds in the amount of herbal cannabis confiscated (22 
tonnes). Average seizures, over 2010–12, were around 2.5 kg, 
and the amount of herbal cannabis intercepted was 109 % of 
the estimated national consumption — an exceptionally high 
rate. These data point to intense cross-border trafficking with 
neighbouring countries, likely of products both of domestic 
origin and from the Balkans.
In recent years, Turkey has emerged as the largest seizing 
country in Europe for herbal cannabis, reaching a new record 
of 125 tonnes in 2012. Although the average size of the 
seizures has declined over the years, it is now around 1.5 
kg, which remains large compared with other countries, and 
points to bulk trafficking, probably of material of domestic 
origin.
In that part of Europe, Bulgaria may also be a place of 
bulk trafficking of herbal cannabis. Although the quantity 
seized — and it is increasing — remains comparatively small 
(1.3 tonnes in 2012), the average size of the intercepted 
shipments (5 kg) is very large. In a context in which criminal 
organisations are tightening their hold on the distribution of 
domestically produced herbal cannabis traditionally grown 
outdoors, these data may reflect intensification both of the 
activity of such groups and of their targeting by the police.
I  Facts and figures 
457 000 the total number of herbal cannabis seizures 
reported in Europe, 2012
230 tonnes the total quantity of herbal cannabis 
intercepted in Europe, 2012
2 050 tonnes the total quantity of cannabis estimated to 
be consumed in Europe 
1 280 tonnes the total quantity of herbal cannabis 
estimated to be consumed in Europe
875 000 the total number of offences reported by the 
police in relation to cannabis in Europe, 2012
78 % the proportion of cannabis-related offences in 
Europe linked to use or possession for use, 2012
5–25 EUR/g the average price of herbal cannabis at 
retail level in Europe, 2012 (range)
3–14 % THC the average THC content in herbal 
cannabis in Europe, 2012 (range)
46 % THC (MAX) the maximum THC content in herbal 
cannabis in Europe, 2012
(1) This designation is without prejudice to positions on status, and is in line with 
UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence.
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South-West Europe
In South-West Europe, Italy and Spain may be developing 
into important production countries for cannabis. They both 
reported the largest increases in seizures of cannabis plants 
in 2012, intercepting 4 million plants in Italy and 40 tonnes in 
Spain.
Italy remains one of the largest seizing countries in Europe 
for herbal cannabis, with 21 tonnes intercepted in 2012. On 
average, the seizures are very large, around 3.3 kg, and the 
total amount seized is estimated to represent 25 % of the 
local market. As well as pointing to increasing production and 
distribution of domestic material, these data may also suggest 
the importation and possible transit of herbal material, for 
instance from the Balkans.
In common with many other European countries, Spain 
has reported a major increase in the quantities of herbal 
cannabis seized in the last two years (reaching 10 tonnes 
in 2012). However, seizures are very small, at about 80 g on 
average, and the total amount recovered amounts to only 5 
% of estimated domestic demand. These data point to local 
trafficking of small quantities, probably of domestic origin. 
Some of the herbal cannabis produced, however, is intended 
for exportation further north; for example in 2013, 15 sites, 
growing 13 000 plants, near Malaga, were dismantled in an 
operation targeting a network of criminals operating between 
Spain and the Netherlands.
North/North-West Europe
Belgium and the Netherlands have long been identified as a 
trafficking hub for both herbal cannabis and cannabis resin. 
In recent years, changes in enforcement in the Netherlands 
have led Dutch commercial growers to transfer some of their 
operations to Belgium, with the produce being exported back 
to the Netherlands for sale in coffee shops. The result is a 
blurring of the boundaries between the two countries with 
respect to cannabis production and supply. Herbal cannabis 
produced in these countries is destined for both domestic 
and export markets, with a large number of countries in 
Europe reporting ‘the Netherlands’ as the source of the drug. 
On a European scale, however, Belgium and the Netherlands 
have been overtaken by other countries for herbal cannabis 
seizures (6 and 13 tonnes respectively seized in 2012). 
These amounts are equivalent to about 15 % of the estimated 
national market in Belgium and 12 % in the Netherlands.
Denmark also appears to be a centre of cannabis production, 
with 1.4 tonnes of cannabis plants seized in 2012. Cannabis 
consumption in Denmark, however, continues to be 
dominated by resin, and some of the herbal cannabis 
produced there is reported to be exported to countries such as 
the Netherlands and Sweden.
The United Kingdom and Germany are estimated to be the 
largest markets for herbal cannabis in the European Union. 
The relatively small average size of seizures (100–200 g) 
in both countries is likely to reflect the large proportion of 
seizures at user level. The amounts intercepted are equivalent 
to 6 % of estimated national demand in the United Kingdom 
and 2 % in Germany. These data suggest a predominance of 
small-scale trafficking, mostly of domestic products.
Herbal cannabis consumed in Germany may also originate 
from the Czech Republic. The Czech Republic and Slovakia 
have become important cannabis producers, supplying 
both their domestic markets and exporting to neighbouring 
countries.
I  Conclusion
The past decade has seen major strides in the application 
of advanced plant breeding, cultivation and processing 
techniques to cannabis production. At the same time, 
Europe’s markets for cannabis products have changed 
fundamentally. Today, more herbal cannabis than resin 
is consumed in the European Union. Increasingly, herbal 
products are being produced in the same countries where 
they are sold and consumed. As production of herbal 
cannabis has increased, signs have appeared that it is also 
being exported to neighbouring countries. 
The increased availability of cultivation equipment and 
technical know-how has facilitated an expansion in the 
number of indoor production sites. This technology has 
allowed organised crime groups involved in cannabis 
production to manage both large-scale plantations and 
multiple smaller sites. Cannabis produced in Europe poses 
a challenge to law enforcement, as it is harder to detect and 
seize than cannabis products shipped into Europe through 
its external borders. This underlines the need for advanced 
detection techniques to support interdiction efforts. 
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In spite of the recent expansion of the European herbal 
cannabis market, Europe is likely to remain one of the 
world’s major consumer markets for cannabis resin. The 
supply of cannabis resin to Europe relies to a large extent 
upon foreign producers, predominantly Morocco, and to a 
lesser extent Afghanistan (EMCDDA, 2012). Recent global 
data suggest that resin from Morocco is consumed mainly 
in western and northern European countries, whereas the 
main consumer markets for Afghan resin are Asian and 
Middle-Eastern countries as well as Russia and Turkey 
(UNODC, 2013a). 
 
According to the latest estimates of global cannabis resin 
production, Afghanistan is the world’s leading producer, 
with 1 300 tonnes in 2011 (1 400 tonnes in 2012), followed 
by Morocco, with 760 tonnes in 2011. The current figures 
for Morocco, however, imply a 75 % reduction in resin 
production between 2003 and 2011, which is not supported 
by seizure data (EMCDDA, 2012; UNODC, 2012, 2013a, 
2013b).  
 
Developments in cannabis cultivation in Morocco may have 
altered the parameters for estimating resin production 
in that country. Recent research in the Rif region, where 
Morocco’s cannabis resin is produced, suggests that the 
farmers now cultivate imported hybrid cannabis plants 
instead of the local kif plant, on which regional resin 
production had traditionally been based. The new hybrids 
are reported to yield three to five times more resin per plant, 
and the resin is said to contain much greater amounts of 
THC than kif plants (Chouvy and Afsahi, in press). 
 
As a result, it is likely that Morocco now produces much 
more cannabis resin than available estimates would 
suggest, and that the resin produced is of higher potency 
than was previously the case. This could explain the 
anomalies found when comparing seizure data in key 
countries such as Algeria, Morocco and Spain with 
estimates of Moroccan resin production and European 
consumption (EMCDDA and Europol, 2013). These 
developments in Morocco may also explain the marked 
increase in cannabis resin potency reported in Europe since 
2009. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
Chouvy, P.-A. and Afsahi, K. (in press), ‘Hashish revival in Morocco’, International 
Journal of Drug Policy. Available online at: http://dx.doi.org/10.1016/j.
drugpo.2014.01.001
EMCDDA (2012), Cannabis production and markets in Europe, EMCDDA 
Insights Series No 12, Publication Office of the European Union, Luxembourg. 
Available online at: http://www.emcdda.europa.eu/publications/insights/
cannabis-market
EMCDDA and Europol (2013), EU Drug markets report: a strategic analysis, 
Publication Office of the European Union, Luxembourg. Available online at: 
http://www.emcdda.europa.eu/publications/joint-publications/drug-markets
UNODC (2012), World Drug Report 2012, United Nations, New York. 
UNODC (2013a), World Drug Report 2013, United Nations, New York. 
UNODC (2013b), Afghanistan. Survey of commercial cannabis cultivation and 
production 2012, Islamic Republic of Afghanistan Ministry of Counter Narcotics 
and United Nations Office on Drugs and Crime, September. Available online at: 
http://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghan_
Opium_survey_2013_web_small.pdf 
 
 
 
Origin of cannabis resin consumed in Europe and production estimates    
PERSPECTIVES ON DRUGS I New developments in Europe’s cannabis market
I  Decorte, T. (2010), ‘The case for small-scale domestic cannabis cultivation’, 
International Journal of Drug Policy 21, pp. 271–275.
I  EMCDDA (2012a), Cannabis production and markets in Europe, EMCDDA Insights 
Series No 12, Luxembourg: Publications Office of the European Union. Available online 
at: http://www.emcdda.europa.eu/publications/insights/cannabis-market
I  EMCDDA (2012b), Reitox 2011 and 2012 national reports to the EMCDDA. Available 
online at: http://www.emcdda.europa.eu/publications/searchresults?action=list&type=
PUBLICATIONS&SERIES_PUB=w203
I  EMCDDA and Europol (2013), EU Drug markets report: a strategic analysis, 
Publications Office of the European Union, Luxembourg. Available online at: http://
www.emcdda.europa.eu/publications/joint-publications/drug-markets
I  Jansen, A. C. M. (2002), ‘The economics of cannabis-cultivation in Europe’, paper 
presented at the 2nd European Conference on Drug Trafficking and Law enforcement, 
Paris, 26–27 September 2002. Available online at: http://www.cedro-uva.org/lib/
jansen.economics.html
I  Potter, G. (2008), ‘The growth of cannabis cultivation: explanations for import 
substitution in the UK’, in Korf, D. J. (ed.) Cannabis in Europe: dynamics and 
perceptions, policy and markets, Pabst Science Publishers, Lengerich, pp. 87–105.
I  Potter, D. J. and Duncombe, P. (2012), ‘The effect of electric lighting power and 
irradiance on indoor-grown cannabis potency and yield’, Journal of Forensic Sciences 
57, pp. 618–622.
I  UNODC (2006), ‘Review of the world cannabis situation’, Bulletin on Narcotics, Volume 
LVIII, Nos. 1 and 2. Available online at: http://www.unodc.org/documents/data-and-
analysis/bulletin/2006/Bulletin_on_Narcotics_2006_En.pdf
I  Vanhove, W., Surmont, T., Van Damme, P. and De Ruyver, B. (2012), ‘Yield and turnover 
of illicit indoor cannabis (Cannabis spp.) plantations in Belgium’, Forensic Science 
International 221(1–3), pp. 265–270.
References
Video on new developments in Europe‘s cannabis market, available on the 
EMCDDA website: emcdda.europa.eu/topics/pods/cannabis-markets-
developments
I  Interactive element: video
